Literature DB >> 23703934

Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: competing factors influence mortality, myocardial infarction, and target lesion revascularization.

Jason C Kovacic1, Atul M Limaye, Samantha Sartori, Paul Lee, Roshan Patel, Sweta Chandela, Biana Trost, Swathi Roy, Rafael Harari, Birju Narechania, Rucha Karajgikar, Michael C Kim, Prakash Krishnan, Pedro Moreno, Usman Baber, Roxana Mehran, George Dangas, Annapoorna S Kini, Samin K Sharma.   

Abstract

OBJECTIVES: To compare the discriminatory value of differing risk scores for predicting clinical outcomes following PCI in routine practice.
BACKGROUND: Various risk scores predict outcomes after PCI. However, these scores consider markedly different factors, from purely anatomical (SYNTAX risk score [SRS]) to purely clinical (ACEF, modified ACEF [ACEFmod], NCDR), while other scores combine both elements (Clinical SYNTAX score [CSS], NY State Risk Score [NYSRS]).
METHODS: Patients with triple vessel and/or LM disease with 12 month follow-up were studied from a single center PCI registry. Exclusion criteria included STEMI presentation, prior revascularization and shock. Clinical events at 12 months were compared to baseline risk scores, according to score tertiles and area under receiver-operating-characteristic curves (AUC).
RESULTS: We identified 584 eligible patients (69.8±12.3yrs, 405 males). All scores were predictive of mortality, with the SRS being least predictive (AUC=0.66). The most accurate scores for mortality were the CSS and ACEF (AUC=0.76 for both: P = 0.019 and 0.08 vs. SRS, respectively). For TLR, while the SRS trended toward being positively predictive (P = 0.075), several scores trended towards a negative association, which reached significance for the NCDR (P = 0.045). The SRS and CSS were the only scores predictive of MI (both P < 0.05). No score was particularly accurate for predicting MACE (death+MI+TLR), with AUCs ranging from 0.53 (NCDR) to 0.63 (SRS).
CONCLUSIONS: Competing factors influence mortality, MI and TLR after PCI. An increasing burden of comorbidities is associated with mortality, whereas anatomical complexity predicts MI. By combining these outcomes to predict MACE, all scores show reduced utility.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  atherosclerosis; coronary artery disease; risk score; stenting

Mesh:

Year:  2013        PMID: 23703934      PMCID: PMC4155404          DOI: 10.1002/ccd.25008

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  34 in total

1.  Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention.

Authors:  F S Resnic; L Ohno-Machado; A Selwyn; D I Simon; J J Popma
Journal:  Am J Cardiol       Date:  2001-07-01       Impact factor: 2.778

2.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

3.  Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease.

Authors:  Davide Capodanno; Maria Elena Di Salvo; Glauco Cincotta; Marco Miano; Claudia Tamburino; Corrado Tamburino
Journal:  Circ Cardiovasc Interv       Date:  2009-06-30       Impact factor: 6.546

4.  5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions.

Authors:  Patrick W Serruys; Yoshinobu Onuma; Scot Garg; Pascal Vranckx; Bernard De Bruyne; Marie-Claude Morice; Antonio Colombo; Carlos Macaya; Gert Richardt; Jean Fajadet; Christian Hamm; Monique Schuijer; Tessa Rademaker; Kristel Wittebols; Hans Peter Stoll
Journal:  J Am Coll Cardiol       Date:  2010-02-18       Impact factor: 24.094

5.  Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.

Authors:  Davide Capodanno; Anna Caggegi; Marco Miano; Glauco Cincotta; Fabio Dipasqua; Giuseppe Giacchi; Piera Capranzano; Gianpaolo Ussia; Maria Elena Di Salvo; Alessio La Manna; Corrado Tamburino
Journal:  JACC Cardiovasc Interv       Date:  2011-03       Impact factor: 11.195

6.  Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study).

Authors:  David M Shahian; Sean M O'Brien; Shubin Sheng; Frederick L Grover; John E Mayer; Jeffrey P Jacobs; Jocelyn M Weiss; Elizabeth R Delong; Eric D Peterson; William S Weintraub; Maria V Grau-Sepulveda; Lloyd W Klein; Richard E Shaw; Kirk N Garratt; Issam D Moussa; Cynthia M Shewan; George D Dangas; Fred H Edwards
Journal:  Circulation       Date:  2012-02-23       Impact factor: 29.690

7.  A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials.

Authors:  Scot Garg; Giovanna Sarno; Chrysafios Girasis; Pascal Vranckx; Ton de Vries; Michael Swart; Marco Bressers; Hector M Garcia-Garcia; Gerrit-Anne van Es; Lorenz Räber; Gianluca Campo; Marco Valgimigli; Keith D Dawkins; Stephan Windecker; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2011-06       Impact factor: 11.195

8.  Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group.

Authors:  G T O'Connor; D J Malenka; H Quinton; J F Robb; M A Kellett; S Shubrooks; W A Bradley; M J Hearne; M W Watkins; D E Wennberg; B Hettleman; D J O'Rourke; P D McGrath; T Ryan; P VerLee
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

9.  A risk score to predict bleeding in patients with acute coronary syndromes.

Authors:  Roxana Mehran; Stuart J Pocock; Eugenia Nikolsky; Tim Clayton; George D Dangas; Ajay J Kirtane; Helen Parise; Martin Fahy; Steven V Manoukian; Frederick Feit; Magnus E Ohman; Bernard Witzenbichler; Giulio Guagliumi; Alexandra J Lansky; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

10.  Assessment of the SYNTAX score in the Syntax study.

Authors:  Patrick W Serruys; Yoshinobu Onuma; Scot Garg; Giovanna Sarno; Marcel van den Brand; Arie-Pieter Kappetein; Nic Van Dyck; Michael Mack; David Holmes; Ted Feldman; Marie-Claude Morice; Antonio Colombo; Eric Bass; Katrin Leadley; Keith D Dawkins; Gerrit-Anne van Es; Marie-Angèle M Morel; Friedrich W Mohr
Journal:  EuroIntervention       Date:  2009-05       Impact factor: 6.534

View more
  7 in total

Review 1.  Paclitaxel-eluting stents versus sirolimus-eluting stents in patients with diabetes mellitus undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Hui-Bo Wang; Ping Zeng; Jun Yang; Jian Yang; Xiao-Wen Liu
Journal:  Intern Emerg Med       Date:  2016-09-08       Impact factor: 3.397

Review 2.  New vessel formation in the context of cardiomyocyte regeneration--the role and importance of an adequate perfusing vasculature.

Authors:  Katherine C Michelis; Manfred Boehm; Jason C Kovacic
Journal:  Stem Cell Res       Date:  2014-04-29       Impact factor: 2.020

Review 3.  Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.

Authors:  S Harada; Y Zhou; S Duncan; A R Armstead; G M Coshatt; C Dillon; B C Brott; J Willig; J A Alsip; W B Hillegass; N A Limdi
Journal:  Clin Pharmacol Ther       Date:  2017-06-01       Impact factor: 6.875

4.  The HDAC9-associated risk locus promotes coronary artery disease by governing TWIST1.

Authors:  Lijiang Ma; Nicole S Bryce; Adam W Turner; Antonio F Di Narzo; Karishma Rahman; Yang Xu; Raili Ermel; Katyayani Sukhavasi; Valentina d'Escamard; Nirupama Chandel; Bhargavi V'Gangula; Kathryn Wolhuter; Daniella Kadian-Dodov; Oscar Franzen; Arno Ruusalepp; Ke Hao; Clint L Miller; Johan L M Björkegren; Jason C Kovacic
Journal:  PLoS Genet       Date:  2022-06-17       Impact factor: 6.020

5.  Validation of Scoring Systems That Predict Outcomes in Patients With Coronary Artery Disease Undergoing Coronary Artery Bypass Grafting Surgery.

Authors:  Wen-Jung Chung; Chung-Yu Chen; Fan-Yen Lee; Chia-Chen Wu; Shu-Kai Hsueh; Cheng-Jei Lin; Chi-Ling Hang; Chiung-Jen Wu; Cheng-I Cheng
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

6.  Multiple independent mechanisms link gene polymorphisms in the region of ZEB2 with risk of coronary artery disease.

Authors:  Lijiang Ma; Nirupama Chandel; Raili Ermel; Katyayani Sukhavasi; Ke Hao; Arno Ruusalepp; Johan L M Björkegren; Jason C Kovacic
Journal:  Atherosclerosis       Date:  2020-08-29       Impact factor: 5.162

7.  Additive Prognostic Value of Carotid Plaque Score to Enhance the Age, Creatinine, and Ejection Fraction Score in Patients with Acute Coronary Syndrome.

Authors:  Takuya Nakahashi; Hayato Tada; Kenji Sakata; Akihiro Nomura; Miho Ohira; Mika Mori; Masayuki Takamura; Kenshi Hayashi; Masakazu Yamagishi; Masa-Aki Kawashiri
Journal:  J Atheroscler Thromb       Date:  2018-01-26       Impact factor: 4.928

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.